Outcomes of Diagnostic Exome Sequencing in Patients With Diagnosed or Suspected Autism Spectrum Disorders Mari Rossi, LPhil, Dima El-Khechen, MS, CGC, LGC, Mary Helen Black, PhD, Kelly D. Farwell Hagman, MS, CGC, LGC, Sha Tang, PhD, DABMG, Zöe Powis, MS, CGC Pediatric Neurology Volume 70, Pages 34-43.e2 (May 2017) DOI: 10.1016/j.pediatrneurol.2017.01.033 Copyright © 2017 The Authors Terms and Conditions
Figure 1 Data analysis strategy. (The color version of this figure is available in the online edition.) Pediatric Neurology 2017 70, 34-43.e2DOI: (10.1016/j.pediatrneurol.2017.01.033) Copyright © 2017 The Authors Terms and Conditions
Figure 2 Diagnostic yield for characterized genetic etiologies and reanalysis results. *Candidate or suspected candidate genetic etiology was reported in seven families and in three cases; clinical significance was corroborated by new pertinent information. **Five more cases were reclassified as positive due to proactive reanalysis based on new publications and further familial cosegregation analysis. (The color version of this figure is available in the online edition.) Pediatric Neurology 2017 70, 34-43.e2DOI: (10.1016/j.pediatrneurol.2017.01.033) Copyright © 2017 The Authors Terms and Conditions
Supplementary Figure 1 Result categories in the ASD cohort. Char, characterized genetic etiology; cand, candidate genetic etiology. *P = 0.05. Pediatric Neurology 2017 70, 34-43.e2DOI: (10.1016/j.pediatrneurol.2017.01.033) Copyright © 2017 The Authors Terms and Conditions